Nuvation Bio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $31,687 | $83,228 | $41,865 | $13,120 |
Gross Profit | 30,776 | 77,612 | 41,442 | 9,771 |
EBITDA | -55,545 | 12,641 | -29,380 | -54,757 |
EBIT | -56,081 | 12,105 | -29,919 | -55,291 |
Net Income | -62,840 | 5,397 | -36,592 | -55,792 |
Net Change In Cash | 31,687 | 83,228 | 41,865 | 13,120 |
Free Cash Flow | -5,021 | 5,021 | -29,822 | -52,901 |
Cash | 258,604 | 125,391 | 164,086 | 98,897 |
Basic Shares | 348,770 | 377,521 | 344,339 | 342,393 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $62,902 | $7,873 | $0 | $0 |
Gross Profit | 54,460 | 795 | -222 | -484 |
EBITDA | -189,206 | -566,915 | -75,580 | -104,000 |
EBIT | -190,945 | -567,598 | -75,802 | -104,199 |
Net Income | -204,627 | -567,939 | -75,802 | -104,199 |
Net Change In Cash | 62,902 | 7,873 | 0 | 0 |
Cost of Revenue | -31,324 | |||
Free Cash Flow | -173,781 | -130,575 | -68,068 | -96,478 |
Cash | 164,086 | 35,723 | 42,649 | 101,099 |
Basic Shares | 341,541 | 268,772 | 218,880 | 216,721 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.15 |
2026-03-31 | $0.01 |
2025-12-31 | -$0.11 |
2025-09-30 | -$0.16 |